LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

MRK

115.79

-0.22%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

MRK

115.79

-0.22%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

MRK

115.79

-0.22%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

MRK

115.79

-0.22%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

MRK

115.79

-0.22%↓

Inicio・Lista de Acciones・Avidity Biosciences Inc

Avidity Biosciences Inc

Cerrado

SectorSanidad

15.05 4.51

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

15.05

Máximo

15.05

Métricas clave
By Trading Economics
Ingresos	-63M -237M
Ventas	-12M 860K
BPA	-1.27
Margen de beneficios	-27,569.884
Empleados	511
EBITDA	-59M -232M

Recomendaciones
By TipRanks
Recomendaciones	Neutral
Estimación a 12 Meses	-0.1% downside

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	-9B 2.3B
Apertura anterior	10.54
Cierre anterior	15.05

Puntuación técnica

By Trading Central

Confianza

Strong Bearish Evidence

25.575 / 32.65 Soporte y Resistencia

Avidity Biosciences Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

5 mar 2026, 23:01 UTC

Ganancias

Costco Evaluating Possibility of Tariff Refunds as 2Q Revenue Rises - Update

5 mar 2026, 21:54 UTC

Ganancias

Costco Posts Higher 2Q Profit on Rising Sales, Membership Fees

5 mar 2026, 21:35 UTC

Principales Movimientos del Mercado

ServiceNow Shares Rise After CEO Says AI Can Add Value to Software

6 mar 2026, 00:00 UTC

Noticias de Eventos Importantes

Its Missile Threat Degraded, Iran Is Taking Fewer Shots at More Targets -- WSJ

5 mar 2026, 23:46 UTC

Charlas de Mercado

Nikkei May Decline Amid Concerns About Energy Costs -- Market Talk

5 mar 2026, 23:33 UTC

Charlas de Mercado

Gold Edges Higher on Possible Technical Recovery -- Market Talk

5 mar 2026, 23:27 UTC

Charlas de Mercado

Middle East Fighting Will Prompt RBA to Delay Hike -- Market Talk

5 mar 2026, 22:54 UTC

Charlas de Mercado

Ganancias

Costco Sold a $150,000 Diamond Ring in 2Q -- Market Talk

5 mar 2026, 22:50 UTC

Charlas de Mercado

Woodside Has More Exposure to Rising Gas Prices Than Santos -- Market Talk

5 mar 2026, 22:48 UTC

Ganancias

Nike Reports $300 Million Pretax Charge Related to Job Cuts -- Barrons.com

5 mar 2026, 22:46 UTC

Ganancias

Costco Evaluating Possibility of Tariff Refunds as 2Q Revenue Rises -- Update

5 mar 2026, 22:44 UTC

Ganancias

Costco Earnings Beat Expectations as Membership Model Shines -- Barrons.com

5 mar 2026, 21:50 UTC

Charlas de Mercado

Tech, Media & Telecom Roundup: Market Talk

5 mar 2026, 21:50 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

5 mar 2026, 21:50 UTC

Charlas de Mercado

Health Care Roundup: Market Talk

5 mar 2026, 21:35 UTC

Ganancias

Marvell Earnings Beat Estimates on 'Robust' AI Demand. The Stock Jumps. -- Barrons.com

5 mar 2026, 21:32 UTC

Ganancias

Costco Earnings Beat Expectations as Membership Model Shines -- Barrons.com

5 mar 2026, 21:26 UTC

Ganancias

These Stocks Are Today's Movers: Broadcom, Trade Desk, Berkshire Hathaway, Rigetti, Corning, Ciena, Expedia, and More -- Barrons.com

5 mar 2026, 21:24 UTC

Ganancias

Costco February Digitally-Enabled Sales Ex-Changes in Gas and Foreign Exchange Rose 20.8% >COST

5 mar 2026, 21:23 UTC

Ganancias

Costco February Same-Store Sales Ex-Changes in Gas and Foreign Exchange Rose 7% >COST

5 mar 2026, 21:22 UTC

Ganancias

Costco 2Q Same-Store Sales Ex-Changes in Gas and Foreign Rose 6.7% >COST

5 mar 2026, 21:21 UTC

Ganancias

Costco February Digitally-Enabled Sales Rose 21.8% >COST

5 mar 2026, 21:21 UTC

Ganancias

Costco Total Co Comparable Sales for February Rose 7.9% >COST

5 mar 2026, 21:20 UTC

Ganancias

Costco February Net Sales Were $21.69 B >COST

5 mar 2026, 21:20 UTC

Ganancias

Marvell Earnings Beat Estimates on 'Robust' AI Demand. The Stock Jumps. -- Barrons.com

5 mar 2026, 21:20 UTC

Ganancias

Costco Same-Store Sales Ex-Changes in Gas and Foreign Rose 6.7% >COST

5 mar 2026, 21:19 UTC

Ganancias

Costco 2Q Digitally-Enabled Sales Ex-Changes in Gas and Foreign Exchange Rose 21.7% >COST

5 mar 2026, 21:18 UTC

Ganancias

Costco 2Q Digitally-Enabled Sales Rose 22.6% >COST

5 mar 2026, 21:18 UTC

Ganancias

Costco 2Q Same-Store Sales Up 7.4% >COST

5 mar 2026, 21:15 UTC

Ganancias

Costco 2Q EPS $4.58 >COST

Comparación entre iguales

Cambio de precio

Avidity Biosciences Inc previsión

Precio Objetivo

By TipRanks

-0.1% descenso

Estimación a 12 Meses

Media 72.75 USD -0.1%

Máximo 75 USD

Mínimo 72 USD

De acuerdo con 4 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Avidity Biosciences Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

4 ratings

Comprar

Mantener

Vender

De acuerdo con 4 analistas que ofrecen calificaciones bursátiles a para Avidity Biosciences Inc Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

25.575 / 32.65Soporte y Resistencia

Recent bearish events outweigh bullish events.

The bullish and bearish events are balanced.

Recent bearish events outweigh bullish events.

Finanzas

Acerca de Avidity Biosciences Inc

Avidity Biosciences, Inc., a biopharmaceutical company, engages in the delivery of RNA therapeutics. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat diseases previously untreatable with RNA therapeutics. The company's lead product candidate AOC 1001 for the treatment of myotonic dystrophy type 1, a rare monogenic muscle disease that is in phase 1/2 clinical trial. Its other products in pipeline include AOC 1044 for the treatment of duchenne muscular dystrophy, which is under phase 1/2 clinical development trial; and AOC 1020 to treat facioscapulohumeral muscular dystrophy that is in phase 1/2 clinical trial. The company is developing products for rare skeletal muscle and rare cardiac diseases. Avidity Biosciences, Inc. was incorporated in 2012 and is headquartered in San Diego, California.